ONCALIS AG
Oncalis AG operates as a biotech company that focused on the discovery and development of small molecule kinase inhibitors for oncology indications using its proprietary yeast-cell based, high-throughput screening platform for receptor tyrosine kinases.
ONCALIS AG
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Status:
Active
Contact:
+41 44 733 49 00
Similar Organizations
Kallistem
Kallistem is a biotech company
More informations about "Oncalis AG"
Oncalis - VentureRadar
Oncalis AG is a spin-off from ESBATech AG, a biotechnology company that has developed technology platforms in both the antibody and small molecule areas of pharmaceutical …See details»
Oncalis AG - Schlieren, Switzerland - bionity.com
Oncalis AG is a drug development company based in Schlieren near Zurich, Switzerland, focused on the development of orally available kinase inhibitors for the treatment of cancer. Kinase …See details»
Oncalis AG - Company Profile and News - Bloomberg Markets
Company profile page for Oncalis AG including stock price, company news, executives, board members, and contact informationSee details»
Oncalis AG:Company Profile & Technical Research,Competitor …
Oncalis AG is a company that provides Tyrosine, High-throughput screening, Kinase and more. Oncalis AG is headquartered in Switzerland ZURICH. Oncalis AG was founded in 2006. …See details»
Oncalis AG - Company Profile & Staff Directory - ContactOut
Oncalis AG is a biotechnology company based out of 21 Wagistrasse, Schlieren, ZH, Switzerland. Get verified email of Oncalis AG employees. Search Oncalis AG Staff Directory. Find accurate …See details»
Oncalis AG - Drug pipelines, Patents, Clinical trials - Synapse
100 Translational Medicine associated with Oncalis AG. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full example data. …See details»
Oncalis AG, Zug, Switzerland ︎ - North Data
Oncalis AG, Zug, Switzerland, Schweizer Handelsregister CHE-113.001.937: Network, Financial informationSee details»
Oncalis AG - Crunchbase
Oncalis AG operates as a biotech company. Start Free Trial . Chrome ExtensionSee details»
Oncalis AG - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Oncalis AG . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit Patents and Trademarks …See details»
10.06.2008 – Oncalis AG licenses PI3K inhibitors from ChemDiv, Inc.
Oct 6, 2008 Oncalis AG Didier Coquoz Chief Executive Officer Wagistrasse 21 CH-8952 Schlieren, Switzerland Phone +41 21 691 50 31 [email protected] …See details»
Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
Oct 6, 2008 Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc. SCHLIEREN, Switzerland, LAUSANNE, Switzerland and SAN DIEGO, Oct. 6 /PRNewswire/ -- Oncalis AG (Oncalis), a …See details»
Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
SCHLIEREN, Switzerland, LAUSANNE, Switzerland and SAN DIEGO, October 6 /PRNewswire/ --Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. …See details»
ESBATech Spins Out Oncalis For Oncology Drug Discovery
Sep 13, 2006 BioWorld International Correspondent. One month after closing a $41 million Series B round, ESBATech AG spun out a new company, Oncalis AG, to take charge of its …See details»
Oncalis AG Licenses PI3K Inhibitors From ChemDiv, Inc.
Oct 6, 2008 Oncalis AG is a drug development company based in Schlieren near Zurich, Switzerland supported by VI Partners, Zurcher KantonalBank and private investors. Oncalis …See details»
Oncalis AG And ChemDiv, Inc. Announce Broad And Far Reaching …
ZURICH and SAN DIEGO, Oct. 3 /PRNewswire/ -- Oncalis AG of Schlieren, Switzerland, and ChemDiv, Inc. of San Diego have announced a far reaching Research and Development …See details»
Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. (ChemDiv), a privately-owned,California-based discovery services company announced that …See details»
ONCALIS AG - US Patent and Trademark Search
ONCALIS AG. Patent Applications and Registrations Patent applications and USPTO patent grants for ONCALIS AG.The latest application filed is for "genetic selection system to identify …See details»
Oncalis licenses PI3K inhibitor from ChemDiv
Oct 12, 2008 Oncalis AG, a privately-owned Swiss biotechnology firm, and ChemDiv, a private, California, USA-based discovery licensing to the former a family of PI3K inhibitors. ONC -201, …See details»
Oncalis AG | www.inknowvation.com
Oncalis AG Profile last edited on: 2/16/2017. NO Business Identifier is currently available for this company. TS Type N/A. Status N/A. Year Founded----Last Involved Year N/A. Key People / …See details»